A comprehensive view of Drug Delivery / Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck reports three failures in trials aimed at improving on its immunotherapy drug, Keytruda in combinations with three other drugs; Keytruda had sales of US$18.0B through the first nine months of 2023

European Commission approves Pfizer’s Elrexfio for relapsed and refractory multiple myeloma; more than 50,000 patients in Europe are diagnosed with multiple myeloma each year

Novartis gains FDA approval for Fabhalta as first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria, a rare blood disorder; Fabhalta offers an alternative to existing C5 inhibitor treatments that often leave symptoms uncontrolled

Eli Lilly's obesity treatment Zepbound now available in US following FDA approval, has been added to preferred formulary for Express Scripts, Cigna Healthcare from December 2023; Eli Lilly investing in global manufacturing expansion

Global injectable drug delivery market forecast to grow from US$17.13B in 2021 to US$46.84B by 2029 at a CAGR of 13.4%; growth driven by rise in chronic diseases, increasing elderly population and technological advancements: Data Bridge Market Research

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count